Abstract: A method for remote and nonconnected interaction between an implant having an electrical motor and a transmitter/receiver inverter having an induction source having/connected to a power source for operating the electrical motor including creating modifications in an electromagnetic field by the transmitter/receiver inverter, and transmitting information in the form of binary data from the transmitter/receiver inverter to the implant; and a device for remote and nonconnected interaction with an implant having a transponder including an induction source having/connected to a power source, and means enabling the induction source to create modifications in an electromagnetic field generated in the device to transmit information in the form of binary data to the implant.
Type:
Grant
Filed:
May 23, 2003
Date of Patent:
November 25, 2008
Assignee:
Europlak
Inventors:
Richard Cancel, Richard Wallace, Gerard Sassi
Abstract: A motorized gastric ring or “AGM” including a motor acting on a diameter of the ring and actuated by induction toward an integrated receiving antenna from at least one outer transmitting antenna, wherein the ring includes at least one receiving antenna, the at least one antenna being disoriented relative to a plane extending through the gastric ring, and integrated electronics adapted to substantially optimally use energy received.
Abstract: A prosthesis for correcting urinary stress incontinence in women including right and left para-urethral hemi-prostheses, each of the hemi-prostheses formed of a biocompatible material and in the form of a strip, one end of the strip having a bulged portion and another end of which is adapted to be attached to the aponeurosis of the rectus muscle of the abdomen, and means for attaching the another end to the aponeurosis of the rectus muscle of the abdomen.
Type:
Grant
Filed:
July 12, 2004
Date of Patent:
May 15, 2007
Assignee:
Europlak
Inventors:
Richard Cancel, Richard Wallace, Gerard Sassi
Abstract: A composition for repairing and cicatrization of cutaneous lesions of chronic or acute wounds including a hydrogel of chitosan, the degree of acetylation of which is no greater than about 40%.